TFEB was previously reported to be associated with poor prognosis in NSCLC samples [32] and mediated lysosomal and autophagosomal biogenesis triggered by inhibition of p53 in lung cancer cells [33]. The gene discussed is TFEB; the disease is lung carcinoma.